Prof. Marta Tesone

University of Buenos Aires, Argentina

Email: [email protected]

Qualifications

1978  Ph.D., Reprod. Endocrin., University of Buenos Aires, Argentina

1972  M.S., Biology, University of Buenos Aires, Argentina

Publications(Selected)

1. Accialini, P., Bechis, A., Irusta, G., et al. (2020). Modulation of the Notch System in Response to Wnt Inhibition Induces Restoration of the Rat Luteal Function. Reproductive Sciences, 27(2), 503-512.
2. Accialini, P., Hernández, S. F., Bas, D., et al. (2015). A link between Notch and progesterone maintains the functionality of the rat corpus luteum. Reproduction, 149(1), 1-10.
3. Accialini, P., Irusta, G., Bechis, A., et al. (2017). Tankyrase inhibition regulates corpus luteum development and luteal function in gonadotropin-treated rats. Molecular Reproduction and Development, 84(8), 719-730.
4. Bocchicchio, S., Tesone, M., & Irusta, G. (2019). Convergence of Wnt and Notch signaling controls ovarian cancer cell survival. Journal of Cellular Physiology, 234(12), 22130-22143.
5. Di Pietro, M., Parborell, F., Irusta, G., et al. (2014). Metformin Treatment Decreases Ovarian VEGF and Angiopoietinl Levels, Improves Follicular Development and Decreases Cyst Formation in a Rat Model of Polycystic Ovary Syndrome. Endocrine Reviews, 35(3), MON-0060.
6. Di Pietro, M., Parborell, F., Irusta, G., et al. (2015). Metformin Regulates Ovarian Angiogenesis and Follicular Development in a Female Polycystic Ovary Syndrome Rat Model. Endocrinology, 156(4), 1453-1463.
7. Di Pietro, M., Pascuali, N., Scotti, L., et al. (2017). In vivo intrabursal administration of bioactive lipid sphingosine-1-phosphate enhances vascular integrity in a rat model of ovarian hyperstimulation syndrome. Molecular Human Reproduction, 23(6), 417-427.
8. Di Pietro, M., Scotti, L., Irusta, G., et al. (2016). Local administration of platelet-derived growth factor B (PDGFB) improves follicular development and ovarian angiogenesis in a rat model of Polycystic Ovary Syndrome. Molecular and Cellular Endocrinology, 433, 47-55.
9. Ferder, I. C., Espeche, L. D., Bruque, C. D., et al. (2022). Expression and characterisation of Fmr1 splice variants during folliculogenesis in the rat. Reproduction Fertility and Development, 34(16), 1034-1042.
10. Irusta, G., Pazos, M. C., Abramovich, D., et al. (2014). Effects of an Inhibitor of the Gamma-Secretase Complex on Proliferation and Apoptotic Parameters in a FOXL2-Mutated Granulosa Tumor Cell Line (KGN) (vol 89, pg 9, 2013). Biology of Reproduction, 91(6), Article 138.
11. Marinoni, R., De Marco, M. J. E., Velazquez, C., et al. (2024). Hypoxia-inducible factor inhibition affects luteal function with no effect on fertility in mice. Reproduction, 169(2), Article e240313.
12. Pascuali, N., Scotti, L., Abramovich, D., et al. (2015). Inhibition of platelet-derived growth factor (PDGF) receptor affects follicular development and ovarian proliferation, apoptosis and angiogenesis in prepubertal eCG-treated rats. Molecular and Cellular Endocrinology, 412, 148-158.
13. Pascuali, N., Scotti, L., Di Pietro, M., et al. (2016). Pharmacological administration of ceramide-1-phosphate (C1P) prevents chemotherapy-induced premature ovarian failure (POF). Human Reproduction, 31(Suppl 1), 125-126.
14. Pascuali, N., Scotti, L., Di Pietro, M., et al. (2018). Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure. Human Reproduction, 33(5), 844-859.
15. Pascuali, N., Scotti, L., Oubiña, G., et al. (2020). Platelet-derived growth factor B restores vascular barrier integrity and diminishes permeability in ovarian hyperstimulation syndrome. Molecular Human Reproduction, 26(8), 585-600.
16. Pazos, M. C., Abramovich, D., Bechis, A., et al. (2017). Gamma secretase inhibitor impairs epithelial-to-mesenchymal transition induced by TGF-β in ovarian tumor cell lines. Molecular and Cellular Endocrinology, 440, 125-137.
17. Pazos, M. C., Sequeira, G., Bocchicchio, S., et al. (2018). PDGFB as a vascular normalization agent in an ovarian cancer model treated with a gamma-secretase inhibitor. Journal of Cellular Physiology, 233(8), 5949-5961.
18. Pazos, M. C., Sequeira, G., Bocchicchio, S., et al. (2024). PDGFB as a vascular normalization agent in an ovarian cancer model treated with a gamma-secretase inhibitor (vol 233, pg 5949, 2018). Journal of Cellular Physiology, 239(11), Article e31354.
19. Scotti, L., Abramovich, D., Pascuali, N., et al. (2014). Local VEGF inhibition prevents ovarian alterations associated with ovarian hyperstimulation syndrome. Journal of Steroid Biochemistry and Molecular Biology, 144(Pt B), 392-401.
20. Scotti, L., Abramovich, D., Pascuali, N., et al. (2016). Inhibition of angiopoietin-1 (ANGPT1) affects vascular integrity in ovarian hyperstimulation syndrome (OHSS). Reproduction Fertility and Development, 28(6), 690-699.

Profile Details
https://uba.academia.edu/MartaTesone/CurriculumVitae
https://www.researchgate.net/profile/Marta-Tesone
https://loop.frontiersin.org/people/792932/overview

WOS ResearcherID: DZO-6625-2022